Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
After-Hours Stock Movers 02/09: (LLNW) (EDE) (MKTO) Higher; (MSTX) (SCTY) (P) Lower (more...)
February 9, 2016 6:12 PM ESTMast Therapeutics, Inc. (NYSE: MSTX) 37% LOWER; announced that it intends to offer shares of common stock and warrants to purchase common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
SolarCity (Nasdaq: SCTY) 32.4% LOWER; reported Q4 EPS of ($2.37), $0.22 better than the analyst estimate of ($2.59). Revenue was $115 million, versus... More
Arrowhead Research (ARWR) Tops Q2 EPS by 9c
February 9, 2016 4:47 PM ESTArrowhead Research (NASDAQ: ARWR) reported Q2 EPS of ($0.32), $0.09 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.
... More